Hot Life Science Investor Mandate 2: Family Office Allocates Based on Financial Needs of Company

18 Dec

A group of accredited investors based in the Eastern US is made up of healthcare professionals seeking to invest in technologies that significantly advance the standard of care. The group considers companies from seed to later stage and is geographically agnostic. Since the members are investing their own capital, the investment size and capital structure are highly flexible and will depend on the financial needs of the company. The group is actively seeking new investment opportunities.    

The office is interested in therapeutics, diagnostics, and medical devices. Currently, the group is interested in cell therapy and oncology but is generally agnostic in terms of subsectors and indications. The group is not interested in dermatology. The group will only consider products that have shown clinical efficacy.  Therefore, the group prefers therapeutic products in phase II. The group may consider phase I if it is evidently supported by human efficacy data.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: